Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lutetium (177Lu)-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide

EU orphan designation number: EU/3/07/523   
Active ingredient: Lutetium (177Lu)-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide
Indication: Treatment of gastro-entero-pancreatic neuroendocrine tumours
Sponsor: Advanced Accelerator Applications
20 rue Diesel, F-1630 Saint-Genis-Pouilly, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2008 Orphan designation EMEA/OD/093/07 (2008)449 of 31/01/2008
29/09/2011 Transfer of orphan designation EMEA/OD/093/07/T/01 (2011)7055 of 27/09/2011